Dual TKI Use & Frontline Dara
from OncoPharm Hosted by John Bossaer
Recent FDA updates are discussed including combined use of BRAF & MEK inhibitors, frontline daratumumab (10:20), and your next P & T monograph drug to review.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of OncoPharm?
This episode is 22 minutes long.
When was this OncoPharm episode published?
This episode was published on May 10, 2018.
Can I download this OncoPharm episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.